StockData
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc. (PLRX) stock

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$0.66−0.03 (-4.76%)

Close on Nov 17, 2026Market cap $40.88MP/E –Yield 0.00%

Pliant Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pliant Therapeutics's pe ratio was 1.2× on Jan 29, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 20211.2×+0.1
2020Dec 31, 20201.1×–

More Pliant Therapeutics figures

See a number that looks wrong?